Lv3
310 积分 2024-05-30 加入
Approved delivery strategies for biopharmaceuticals
11天前
已完结
Ocular toxicities of FDA-approved antibody drug conjugates
11天前
已完结
Bispecific Antibodies, Immune Checkpoint Inhibitors, and Antibody−Drug Conjugates Directing Antitumor Immune Responses: Challenges and Prospects
11天前
已完结
Linker Design and Impact on ADC Properties
12天前
已完结
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
13天前
已完结
Optimization of Pharmaceutical Processes
24天前
已完结
Preferential precipitation of acidic variants from monoclonal antibody pools
24天前
已完结
In-line product quality monitoring during biopharmaceutical manufacturing using computational Raman spectroscopy
24天前
已完结
Risk Evaluation of N-Nitrosamines in Drug-Linker Intermediates Used To Generate Antibody–Drug Conjugates
24天前
已完结
Predicting Formulation Conditions During Ultrafiltration and Dilution to Drug Substance Using a Donnan Model with Homology-Model Based Protein Charge
24天前
已完结
皖公网安备34019202002308
